Literature DB >> 22891207

Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?

Paul H Hayashi, Naga P Chalasani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22891207      PMCID： PMC3470615          DOI： 10.1503/cmaj.121270

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  Management of bacterial infections in cirrhosis.

Authors:  Javier Fernández; Thierry Gustot
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  Hepatic adverse drug reactions: a case/non-case study in Italy.

Authors:  Domenico Motola; Antonio Vargiu; Roberto Leone; Alfredo Cocci; Francesco Salvo; Barbara Ros; Ilaria Meneghelli; Mauro Venegoni; Paola Maria Cutroneo; Alberto Vaccheri; Gianpaolo Velo; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2006-11-22       Impact factor: 2.953

3.  Suspected drug-induced liver fatalities reported to the WHO database.

Authors:  E Björnsson; R Olsson
Journal:  Dig Liver Dis       Date:  2005-07-28       Impact factor: 4.088

4.  Management of adult patients with ascites due to cirrhosis: an update.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

5.  Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.

Authors:  J Michael Paterson; Muhammad M Mamdani; Michael Manno; David N Juurlink
Journal:  CMAJ       Date:  2012-08-13       Impact factor: 8.262

6.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

7.  Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.

Authors:  Allen D Brinker; Ronald T Wassel; Jenna Lyndly; Jose Serrano; Mark Avigan; William M Lee; Leonard B Seeff
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 8.  Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors:  Françoise Van Bambeke; Paul M Tulkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data.

Authors:  Robert P Myers; Yvette Leung; Abdel Aziz M Shaheen; Bing Li
Journal:  BMC Health Serv Res       Date:  2007-10-02       Impact factor: 2.655
  9 in total
  1 in total

1.  Safety of Delafloxacin: Focus on Adverse Events of Special Interest.

Authors:  Thomas Lodise; Ralph Corey; David Hooper; Sue Cammarata
Journal:  Open Forum Infect Dis       Date:  2018-09-10       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.